JIFI: Indonesian Journal of Pharmaceutical Sciences Sets Sights on Scopus Indexing

JAKARTA, May 13, 2026 — Led by Editor-in-Chief Dr. apt. Diah Kartika Pratami, M.Farm., the full editorial board of the Indonesian Journal of Pharmaceutical Sciences (JIFI) convened today for a high-level strategic meeting aimed at reinforcing the journal’s academic standing. The session focused on finalizing a modernized framework to meet the rigorous demands of global scientific publishing.

The editorial team prioritized several key updates to the journal's operations:

1. Refining the House Style (Gaya Selingkung): Enhancing the journal's specific writing and formatting guidelines to ensure the highest level of clarity and professional consistency in pharmaceutical research.

2. AI Integration Framework: Establishing formal policies regarding the use of Artificial Intelligence in research and manuscript preparation, prioritizing academic integrity and ethical transparency.

3. Comprehensive Policy Review: Updating all internal regulations and publication policies to align with the latest international standards.

"Our focus today goes beyond the next issue; we are building the infrastructure required for National Accreditation and our primary goal of Scopus International Indexing," noted Dr. apt. Diah Kartika Pratami. "Strengthening our house style and AI policies ensures JIFI remains a premier, trusted destination for pharmaceutical breakthroughs."

This strategic coordination marks a significant step in JIFI's mission to elevate Indonesian pharmaceutical research to the global stage, ensuring every publication adheres to world-class editorial benchmarks.

Photo: Dr. apt. Diah Kartika Pratami and the JIFI Editorial Board during their working session on May 13, 2026, discussing the strategic roadmap for the journal’s international expansion.